Peter Stein
Impact in
-
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Research
- Physiology top 5%
- Alzheimer's disease research and treatments
- Adipose Tissue and Metabolism
Papers in
-
- Diabetes Treatment and Management 8
-
- Pharmacovigilance and Adverse Drug Reactions 3
- Co-authors
- Gerald I. Shulman (2 shared papers)Ralph A. DeFronzo (2 shared papers)Thomas Jue (1 shared paper)Robert G. Shulman (1 shared paper)Douglas L. Rothman (1 shared paper)Ronald Brazg (1 shared paper)Kaifeng Lu (1 shared paper)Julio Rosenstock (1 shared paper)
- Journals
- New England Journal of Medicine (4 papers)Canadian Journal of Diabetes (2 papers)Clinical Pharmacology & Therapeutics (2 papers)Diabetes Obesity and Metabolism (2 papers)Therapeutic Innovation & Regulatory Science (2 papers)
- Partner nations
- United StatesAustraliaNetherlands
In The Last Decade
Peter Stein
21 papers receiving 2.9k citations
Peter Stein's Hit Papers
Peers
Comparison fields: 5 of 91
- Endocrinology, Diabetes and Metabolism 2k
- Physiology 326
- Molecular Biology 593
- Complementary and alternative medicine 51
- Nephrology 49
Countries citing papers authored by Peter Stein
This map shows the geographic impact of Peter Stein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Stein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Stein more than expected).
Fields of papers citing papers by Peter Stein
This network shows the impact of papers produced by Peter Stein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Stein. The network helps show where Peter Stein may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Stein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Quantitation of Muscle Glycogen Synthesis in Normal Subjects and Subjects with Non-Insulin-Dependent Diabetes by13C Nuclear Magnetic Resonance Spectroscopy Hit paper breakdown → | 1990 | 1062 |
| 2 | 2006 | 445 | |
| 3 | 2007 | 434 | |
| 4 | 2013 | 290 | |
| 5 | 2014 | 232 | |
| 6 | 2006 | 222 | |
| 7 | Approval of Aducanumab for Alzheimer Disease—The FDA’s Perspective Hit paper breakdown → | 2021 | 199 |
| 8 | 1990 | 94 | |
| 9 | 2014 | 45 | |
| 10 | 2021 | 33 | |
| 11 | 2020 | 32 | |
| 12 | 2018 | 19 | |
| 13 | 2018 | 15 | |
| 14 | 2023 | 11 | |
| 15 | 2021 | 6 | |
| 16 | 2013 | 5 | |
| 17 | 2017 | 5 | |
| 18 | 2020 | 4 | |
| 19 | 2013 | 2 | |
| 20 | 2020 | 2 |
About Peter Stein
Peter Stein is a scholar working on Endocrinology, Diabetes and Metabolism, Toxicology, Statistics and Probability, Economics and Econometrics and Health Information Management, having authored 21 papers that have together received 3.2k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (8 papers), Pharmaceutical Economics and Policy (6 papers), Statistical Methods in Clinical Trials (4 papers), Pharmacovigilance and Adverse Drug Reactions (3 papers), Pharmaceutical industry and healthcare (3 papers), Healthcare Regulation (3 papers), Alzheimer's disease research and treatments (2 papers) and Metabolism, Diabetes, and Cancer (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2k citations), Physiology (326 citations), Molecular Biology (593 citations), Complementary and alternative medicine (51 citations) and Nephrology (49 citations). Peter Stein has collaborated with scholars based in United States, Australia and Netherlands. Frequent co-authors include Gerald I. Shulman, Ralph A. DeFronzo, Thomas Jue, Robert G. Shulman, Douglas L. Rothman, Ronald Brazg, Kaifeng Lu, Julio Rosenstock, Patrizia A. Cavazzoni and Billy Dunn. Their work appears in journals such as New England Journal of Medicine, Canadian Journal of Diabetes, Clinical Pharmacology & Therapeutics, Diabetes Obesity and Metabolism and Therapeutic Innovation & Regulatory Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.